Dr. Porter provides state-of-the-art, minimally invasive treatment options to patients with urologic cancer and stone disease to reduce the pain and recovery from surgical treatment. He stays current on the latest available treatments by teaching at national and international urologic meetings as well as publishing his outcomes. Dr. Porter was the 2023 recipient of the Menon Award in Robotic Urologic Surgery. Dr. Porter is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Chromophobe Renal Cell Carcinoma, Familial Wilms Tumor 2, WT1-Related Wilms Tumor Syndromes, Vasectomy, and Reconstructive Urology Surgery.

Dr. Zhao believes in providing the best cancer care through multidisciplinary, evidence-based — yet personalized — approaches. Dr. Zhao is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Familial Prostate Cancer.

Dr. Lee feels that open, honest communication is fundamental to the patient-doctor relationship, and strives to partner with her patients in a shared decision-making model of care. Dr. Lee has received both regional and national awards for her research in prostate and kidney cancer outcomes and epidemiology. She completed an advanced robotics fellowship in Seattle, WA. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Familial Wilms Tumor 2, Renal Cell Carcinoma (RCC), Ureterocele, Reconstructive Urology Surgery, and Nephrectomy.

Dr. Somasundaram Subramaniam is a Medical Oncologist at the Swedish Cancer Institute in Seattle, Washington and a 2021 Seattle Met Top Doctor Award winner. He has specialized expertise in the management of Gastrointestinal (GI) Cancers. This includes common cancers like colon and rectal cancers and also less common cancers like stomach cancer, neuroendocrine tumors (NETs) and liver and bile duct cancers. He also treats patients with lung cancer and kidney cancer. Dr. Soma chose to pursue a career in Oncology to help patients diagnosed with very serious illnesses and their families by providing hope, education and the best opportunities for treatment and cure. He is thrilled to be working with at Swedish, which has an excellent group of caring and highly-trained physicians, nurses and providers who all work very closely together with a robust multi-disciplinary team approach.. Dr. Subramaniam is an investigator on several clinical trials and a key member of the Personalized Medicine Research Program at Swedish, which focuses on the using a tumor’s DNA mutations to target it with newer drugs. The Swedish Cancer Institute prioritizes opening cutting-edge clinical trials to ensure patients have access to the latest innovations in cancer therapy. Dr. Subramaniam graduated from medical school at the National University of Singapore and obtained sub-specialty training during his fellowship at Stanford University, which was supported by a T32 training grant awarded by the National Institutes of Health. He is board-certified in Internal Medicine and Medical Oncology. Dr. Subramaniam also earned a Master of Science degree in Epidemiology and Clinical Research from Stanford. In addition to treating patients with cancer, Dr. Subramaniam is the Medical Director of the Cancer Control program, which emphasizes preventative measures and appropriate cancer screening, to reduce the incidence and burden of cancer in our community. Dr. Subramaniam is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Nerve Decompression.

Robert Randolph is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Randolph is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Hemangioma Thrombocytopenia Syndrome, and Pleuropulmonary Blastoma.

Paul Kozlowski, MD, is a board-certified urologist specializing in minimally invasive laparoscopic and robotic surgery for a variety of urologic conditions, including kidney and other urologic cancers, prostate disease and kidney stones (including complex stones). He is experienced with both robotic and radical prostatectomy; renal reconstructive surgery; and ureteropelvic junction obstruction (UPJ). Dr. Kozlowski also offers aquablation treatment for benign prostate hyperplasia (HPB).Dr. Kozlowski strives to put himself in the patient's chair so he can better understand and relieve their concerns and anxieties. He savors his time with his patients and works hard to earn their trust.Dr. Kozlowski is a member of the American Urological Association, Endourological Society and Western Section of the American Urologic Association. He is a Pfizer Scholar in Urology and an associate clinical professor at the University of Washington. Dr. Kozlowski is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Ureterocele, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery.

John Paul Flores, MD, is a board-certified medical oncologist. He cares for patients with blood disorders and all forms of cancer.Dr. Flores takes the time to guide his patients on their wellness journey, listening to what they say, answering their questions and providing a path forward with hope. In this complex, fast-growing field where new treatments are approved for clinical use regularly, Dr. Flores relies on the expertise of a team of surgeons, pathologists, radiation oncologists and other colleagues to stay at the forefront of cancer treatment and to provide comprehensive, patient-centered care. Dr. Flores is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, Prostatectomy, and Splenectomy.

Sasha Joseph is an Oncologist and a Hematologist Oncology provider in Seattle, Washington. Dr. Joseph is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, and Paget Disease of the Breast. Dr. Joseph is currently accepting new patients.

Dr. Lee believes it is his responsibility to provide the medical information necessary for his patients to make informed decisions based on their own personal beliefs and health and wellness goals. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Kidney Stones, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Prostatectomy.

Dr. Torgerson is a 2021 Seattle Met Top Doctor Award winner. He has practiced at Swedish since he completed is residency in 2000. His practice philosophy is that patients should play an integral role in the doctor-patient relationship. He believes patients should make treatment decisions based on the facilitation and education provided by their physician. Because he values his patient's time and effort in visiting him, Dr. Torgerson makes every effort to see his patients in a timely manner. Dr. Torgerson is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Bladder Cancer, Ureteroscopy, and Prostatectomy.

Dr. Evans’ patient encounters focus on mutual respect and open engagement. He enjoys learning about patients and their families, and helping them reach their urologic health goals through lifestyle, medical and surgical care. Dr. Evans is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Reconstructive Urology Surgery.

Scott Tykodi is an Oncologist in Seattle, Washington. Dr. Tykodi is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Adult Soft Tissue Sarcoma, and Nephrectomy. Dr. Tykodi is currently accepting new patients.

Evan Hall is a Hematologist and an Oncologist in Seattle, Washington. Dr. Hall is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Merkel Cell Carcinoma, Melanoma, Renal Cell Carcinoma (RCC), and Clear Cell Sarcoma.

John Thompson is a Hematologist and an Oncologist in Seattle, Washington. Dr. Thompson is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Melanoma, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Chromophobe Renal Cell Carcinoma.

"At the age of three, Dr. Johnston knew exactly what she was going to do as an adult, and she never changed her mind. She was going to be a doctor. During her third year of residency, she encountered outpatient medical oncology. Dr. Johnston is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Johnston draws a special satisfaction from working with a team of compassionate professionals, all dedicated solely to the care of cancer patients. ""Everything here is focused on the patient and on one specialty - cancer care. It's set up to be more efficient, more personalized yet state-of-the art. I know my patients will notice that everything is geared towards them. I like the complexity of oncology, the challenge and the fact that you're bringing the full scope of your medical skills in to caring for your patient as well as their families."" Dr. Johnston enjoys cooking, running, swimming, biking, skiing and spending time with her three, young adult daughters.". Dr. Johnston is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Lynch Syndrome.

Christian Kuhr, MD, is a board-certified urologist with special medical interest in kidney and pancreas transplantation and kidney cancer surgery. Dr. Kuhr's lab focuses on the mechanisms of immune tolerance as they relate to organ transplantation and cancer treatment.Dr. Kuhr feels privileged to work with patients and to witness the transformative effects of transplantation, both for the patients and their families. The process of transplant surgery requires a lot of trust between patient and physician, and Dr. Kuhr works hard to built this trust.Dr. Kuhr is a Fellow of the American College of Surgeons. He is part of Benaroya Research Institute, a clinical associate professor of surgery and urology at the University of Washington, and affiliate in research at Fred Hutchinson Cancer Research Center. He has been named a Top Doctor bySeattle MetropolitanandSeattlemagazines.When not caring for patients or in the laboratory, Dr. Kuhr enjoys spending time with his wife, two children and dog, hiking, climbing, skiing, cycling and running. He also enjoys the outdoors, travel and music. Dr. Kuhr is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery.

Nick Cowan, MD, is a board certified urologist and transplant surgeon specializing in kidney transplant, kidney cancer, kidney stones, and laparoscopic and robotic urologic surgery. He also offers aquablation treatment for benign prostate hyperplasia (BPH).Dr. Cowan is the Urology Residency Program director at Virginia Mason and a clinical assistant professor of urology at the University of Washington. He is a member of the American Urologic Association, and the Urologic Society for Transplantation and Renal Surgery. He serves as a manuscript reviewer withUrology Practice, Urology, Journal of UrologyandClinical Transplantation.Away from work, Dr. Cowan enjoys surfing, skiing and backpacking. Dr. Cowan is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are End-Stage Renal Disease (ESRD), Ureterocele, UPJ Obstruction, Reconstructive Urology Surgery, and Nephrectomy.

Phillip Chapman is a Urologist and a Transplant Surgeon in Seattle, Washington. Dr. Chapman is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Muscle Invasive Bladder Cancer, Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Nephrectomy, and Reconstructive Urology Surgery. Dr. Chapman is currently accepting new patients.

Tina Passalaris is a Hematologist and an Oncologist in Seattle, Washington. Dr. Passalaris is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Passalaris is currently accepting new patients.

Sheldon Goldberg is a Hematologist Oncology provider in Seattle, Washington. Dr. Goldberg is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Waldenstrom Macroglobulinemia, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Factor V Leiden Thrombophilia, and Bone Marrow Aspiration. Dr. Goldberg is currently accepting new patients.